VEGFA and neoplasm: In addition, a combination treatment of anti-angiogenic therapy with immunotherapy to cure metastatic UVM was proposed, based on the theory that targeting vascular endothelial growth factor (VEGF) could not only inhibit angiogenesis, but also change the tumor microenvironment, which would make UVM cells more immune-responsive [10].